<SEC-DOCUMENT>0001437749-17-016130-index.html : 20170920
<SEC-HEADER>0001437749-17-016130.hdr.sgml : 20170920
<ACCEPTANCE-DATETIME>20170920165228
ACCESSION NUMBER:		0001437749-17-016130
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170919
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
FILED AS OF DATE:		20170920
DATE AS OF CHANGE:		20170920

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aviragen Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35285
		FILM NUMBER:		171094389

	BUSINESS ADDRESS:	
		STREET 1:		2500 NORTHWINDS PARKWAY, SUITE 100
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30009
		BUSINESS PHONE:		301-770-3099

	MAIL ADDRESS:	
		STREET 1:		2500 NORTHWINDS PARKWAY, SUITE 100
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Biota Pharmaceuticals, Inc.
		DATE OF NAME CHANGE:	20121113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20100719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI  BIOPHARMACEUTICALS
		DATE OF NAME CHANGE:	20020304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>avir20170920b_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
Document 1 - file: avir20170920b_8k.htm

</DOCUMENT>
</SEC-DOCUMENT>